 Connection
James Suen to Carcinoma, Squamous Cell
This is a "connection" page, showing publications James Suen has written about Carcinoma, Squamous Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.920 |
|
|
|
-
Vural E, Fan CY, Spring P, Stack BC, Kokoska MS, Hanna EY, Suen JY. Evaluation of the inferior and superior laryngeal nerve stumps for perineural spread in laryngeal cancer. Otolaryngol Head Neck Surg. 2007 Dec; 137(6):889-92.
Score: 0.242
-
Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg. 2004 Jul; 130(7):861-7.
Score: 0.191
-
Wolf GT, Fee WE, Dolan RW, Moyer JS, Kaplan MJ, Spring PM, Suen J, Kenady DE, Newman JG, Carroll WR, Gillespie MB, Freeman SM, Baltzer L, Kirkley TD, Brandwein HJ, Hadden JW. Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer. Head Neck. 2011 Dec; 33(12):1666-74.
Score: 0.075
-
Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009 Oct; 141(4):484-90.
Score: 0.069
-
Morgan JE, Breau RL, Suen JY, Hanna EY. Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):10-4.
Score: 0.057
-
Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):967-75.
Score: 0.047
-
Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, Hanna E, Brown KD, Fan CY. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev. 2004 Jan; 13(1):150-6.
Score: 0.046
-
Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol. 2003 Sep; 16(9):944-50.
Score: 0.045
-
Mukunyadzi P, Liu K, Hanna EY, Suen JY, Fan CY. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol. 2003 Aug; 16(8):796-801.
Score: 0.045
-
Liu K, Zuo C, Luo QK, Suen JY, Hanna E, Fan CY. Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol. 2003 Mar; 12(1):50-6.
Score: 0.043
-
Liu K, Huang H, Mukunyadzi P, Suen JY, Hanna E, Fan CY. Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2002 May; 126(5):548-53.
Score: 0.041
-
Furusawa J, Zhang H, Vural E, Stone A, Fukuda S, Oridate N, Fang H, Ye Y, Suen JY, Fan CY. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells. Otolaryngol Head Neck Surg. 2011 Jun; 144(6):900-9.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|